Cargando…

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer

BACKGROUND: Cervical carcinoma develops as a result of multiple genetic alterations. Different studies investigated genomic alterations in cervical cancer mainly by means of metaphase comparative genomic hybridization (mCGH) and microsatellite marker analysis for the detection of loss of heterozygos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kloth, Judith N, Oosting, Jan, van Wezel, Tom, Szuhai, Karoly, Knijnenburg, Jeroen, Gorter, Arko, Kenter, Gemma G, Fleuren, Gert Jan, Jordanova, Ekaterina S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805756/ https://www.ncbi.nlm.nih.gov/pubmed/17311676 http://dx.doi.org/10.1186/1471-2164-8-53

Ejemplares similares

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
por: Mehta, Akash M., et al.
Publicado: (2007)

FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma
por: Punt, Simone, et al.
Publicado: (2015)

Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer
por: Schrevel, Marlies, et al.
Publicado: (2017)

Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer
por: Punt, Simone, et al.
Publicado: (2015)

HLA-E expression in cervical adenocarcinomas: association with improved long-term survival
por: Spaans, Vivian M, et al.
Publicado: (2012)

A high IL6/IL17 ratio combined with low IL5 expression is correlated with poor survival in squamous cervical cancer
por: Punt, Simone, et al.
Publicado: (2014)

Molecular Backgrounds of ERAP1 Downregulation in Cervical Carcinoma
por: Mehta, Akash M., et al.
Publicado: (2015)

Loss of Heterozygosity and Copy Number Alterations in Flow-Sorted Bulky Cervical Cancer
por: van den Tillaart, Sabrina A. H. M., et al.
Publicado: (2013)

Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer
por: Punt, Simone, et al.
Publicado: (2015)

Rapid detection of genomic imbalances using micro-arrays consisting of pooled BACs covering all human chromosome arms
por: Knijnenburg, Jeroen, et al.
Publicado: (2005)

Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations
por: Corver, Willem Ernst, et al.
Publicado: (2011)

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
por: Jonsdottir, Asta Björk, et al.
Publicado: (2009)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Role of IL-12p40 in cervical carcinoma
por: Zijlmans, H J M A A, et al.
Publicado: (2012)

Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study
por: Utami, Tofan Widya, et al.
Publicado: (2022)

Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome
por: Spaans, Vivian M., et al.
Publicado: (2015)

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer
por: Heeren, Marijne, et al.
Publicado: (2014)

Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
por: Heeren, A. Marijne, et al.
Publicado: (2019)

A Review of the Effects of Cervical Cancer Standard Treatment on Immune Parameters in Peripheral Blood, Tumor Draining Lymph Nodes, and Local Tumor Microenvironment
por: van Luijk, Iske F., et al.
Publicado: (2022)

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases
por: Ferns, Debbie M., et al.
Publicado: (2016)

CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients
por: Schrevel, M, et al.
Publicado: (2012)

MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma
por: Sahasrabudhe, Neha M., et al.
Publicado: (2019)

Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival
por: Punt, Simone, et al.
Publicado: (2015)

Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area
por: Heeren, A. Marijne, et al.
Publicado: (2015)

Single Nucleotide Polymorphism (SNP)-Based Loss of Heterozygosity (LOH) Testing by Real Time PCR in Patients Suspect of Myeloproliferative Disease
por: Huijsmans, Cornelis J. J., et al.
Publicado: (2012)

L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer
por: Schrevel, Marlies, et al.
Publicado: (2017)

Genome-wide analysis of Ollier disease: Is it all in the genes?
por: Pansuriya, Twinkal C, et al.
Publicado: (2011)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
por: Kersemaekers, A. M., et al.
Publicado: (1998)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples
por: de Jong, Danielle, et al.
Publicado: (2011)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations
por: Mehta, Akash M., et al.
Publicado: (2015)

Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity.
por: Abeln, E. C., et al.
Publicado: (1994)

‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment
por: Rotman, J., et al.
Publicado: (2018)

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
por: Heeren, A. Marijne, et al.
Publicado: (2018)

The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome
por: Gorter, Arko, et al.
Publicado: (2015)

Single Nucleotide Polymorphisms Associated with Colorectal Cancer Susceptibility and Loss of Heterozygosity in a Taiwanese Population
por: Yang, Chih-Yung, et al.
Publicado: (2014)

Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study
por: Samuels, Sanne, et al.
Publicado: (2016)

Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays
por: Beroukhim, Rameen, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_ho9mrc1auppg70i8mq0uie3020